{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:33:13Z","timestamp":1792225993405,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T00:00:00Z","timestamp":1553126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["3100AO-120633\/1"],"award-info":[{"award-number":["3100AO-120633\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Lausanne"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.metabol.2019.03.003","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T11:59:19Z","timestamp":1552478359000},"page":"8-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Systemic PPAR\u03b3 deletion in mice provokes lipoatrophy, organomegaly, severe type 2 diabetes and metabolic inflexibility"],"prefix":"10.1016","volume":"95","author":[{"given":"Federica","family":"Gilardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Quignodon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Gael","family":"Diserens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Toffoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Schiffrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Sardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Preitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Desvergne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2019.03.003_bb0005","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2019.03.003_bb0010","doi-asserted-by":"crossref","first-page":"T1","DOI":"10.1530\/JOE-13-0584","article-title":"Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms","volume":"220","author":"Guo","year":"2014","journal-title":"J Endocrinol"},{"key":"10.1016\/j.metabol.2019.03.003_bb0015","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1093\/eurheartj\/ehn387","article-title":"Adipose tissue dysfunction in obesity, diabetes, and vascular diseases","volume":"29","author":"Hajer","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2019.03.003_bb0020","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/cbf.1706","article-title":"The role of inflamed adipose tissue in the insulin resistance","volume":"28","author":"Torres-Leal","year":"2010","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.metabol.2019.03.003_bb0025","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/1873-3468.12742","article-title":"From chronic overnutrition to metaflammation and insulin resistance: adipose tissue and liver contributions","volume":"591","author":"Caputo","year":"2017","journal-title":"FEBS Lett"},{"key":"10.1016\/j.metabol.2019.03.003_bb0030","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1017\/S1462399410001547","article-title":"Molecular mechanisms controlling human adipose tissue development: insights from monogenic lipodystrophies","volume":"12","author":"Rochford","year":"2010","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.metabol.2019.03.003_bb0035","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jc.2011-1159","article-title":"Clinical review#: lipodystrophies: genetic and acquired body fat disorders","volume":"96","author":"Garg","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2019.03.003_bb0040","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/S0140-6736(10)60408-4","article-title":"Lipid-induced insulin resistance: unravelling the mechanism","volume":"375","author":"Samuel","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2019.03.003_bb0045","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.clnu.2013.11.003","article-title":"Diets and nonalcoholic fatty liver disease: the good and the bad","volume":"33","author":"Asrih","year":"2014","journal-title":"Clin Nutr"},{"key":"10.1016\/j.metabol.2019.03.003_bb0050","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bbalip.2009.12.006","article-title":"Adipose tissue expandability, lipotoxicity and the metabolic syndrome\u2013an allostatic perspective","volume":"1801","author":"Virtue","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2019.03.003_bb0055","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1097-2765(00)80211-7","article-title":"PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro","volume":"4","author":"Rosen","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/j.metabol.2019.03.003_bb0060","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1073\/pnas.0400356101","article-title":"Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse","volume":"101","author":"Imai","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2019.03.003_bb0065","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.bbalip.2007.03.004","article-title":"Molecular basis of selective PPARgamma modulation for the treatment of type 2 diabetes","volume":"1771","author":"Gelman","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2019.03.003_bb0070","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1210\/me.2004-0088","article-title":"Be fit or be sick: peroxisome proliferator-activated receptors are down the road","volume":"18","author":"Desvergne","year":"2004","journal-title":"Mol Endocrinol"},{"issue":"Suppl. 1","key":"10.1016\/j.metabol.2019.03.003_bb0075","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1038\/sj.ijo.0802911","article-title":"Lessons from human mutations in PPARgamma","volume":"29","author":"Hegele","year":"2005","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.metabol.2019.03.003_bb0080","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1371\/journal.pgen.0030064","article-title":"PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism","volume":"3","author":"Medina-Gomez","year":"2007","journal-title":"PLoS Genet"},{"key":"10.1016\/j.metabol.2019.03.003_bb0085","doi-asserted-by":"crossref","first-page":"18656","DOI":"10.1073\/pnas.1314863110","article-title":"Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARgamma","volume":"110","author":"Wang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2019.03.003_bb0090","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/nm956","article-title":"Muscle-specific Pparg deletion causes insulin resistance","volume":"9","author":"Hevener","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2019.03.003_bb0095","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nature05894","article-title":"Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance","volume":"447","author":"Odegaard","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2019.03.003_bb0100","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1097-2765(00)80209-9","article-title":"PPAR gamma is required for placental, cardiac, and adipose tissue development","volume":"4","author":"Barak","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/j.metabol.2019.03.003_bb0105","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1210\/en.2010-0131","article-title":"PPARgamma in placental angiogenesis","volume":"151","author":"Nadra","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2019.03.003_bb0110","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1172\/JCI28859","article-title":"Hypotension, lipodystrophy, and insulin resistance in generalized PPARgamma-deficient mice rescued from embryonic lethality","volume":"117","author":"Duan","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2019.03.003_bb0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0925-4773(02)00292-7","article-title":"Efficient gene modulation in mouse epiblast using a Sox2Cre transgenic mouse strain","volume":"2","author":"Hayashi","year":"2002","journal-title":"Gene Expr Patterns"},{"key":"10.1016\/j.metabol.2019.03.003_bb0120","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jid.2017.09.024","article-title":"Delayed hair follicle morphogenesis and hair follicle dystrophy in a lipoatrophy mouse model of Pparg total deletion","volume":"138","author":"Sardella","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.metabol.2019.03.003_bb0125","doi-asserted-by":"crossref","first-page":"6908","DOI":"10.1074\/jbc.M113.506394","article-title":"LT175 is a novel PPARalpha\/gamma ligand with potent insulin-sensitizing effects and reduced adipogenic properties","volume":"289","author":"Gilardi","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2019.03.003_bb0130","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.biochem.77.061307.091829","article-title":"Fat and beyond: the diverse biology of PPARgamma","volume":"77","author":"Tontonoz","year":"2008","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.metabol.2019.03.003_bb0135","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.3389\/fimmu.2018.02573","article-title":"Lack of adipocytes alters hematopoiesis in lipodystrophic mice","volume":"9","author":"Wilson","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.metabol.2019.03.003_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19072044","article-title":"PPARgamma controls ectopic adipogenesis and cross-talks with myogenesis during skeletal muscle regeneration","volume":"19","author":"Dammone","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2019.03.003_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171474","article-title":"Nephropathy in Pparg-null mice highlights PPARgamma systemic activities in metabolism and in the immune system","volume":"12","author":"Toffoli","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2019.03.003_bb0150","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1097-2765(00)80210-5","article-title":"PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance","volume":"4","author":"Kubota","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/j.metabol.2019.03.003_bb0155","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1210\/me.2002-0036","article-title":"A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity","volume":"16","author":"Rieusset","year":"2002","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.metabol.2019.03.003_bb0160","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1101\/gad.12.20.3168","article-title":"Life without white fat: a transgenic mouse","volume":"12","author":"Moitra","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/j.metabol.2019.03.003_bb0165","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1093\/hmg\/ddr205","article-title":"Seipin ablation in mice results in severe generalized lipodystrophy","volume":"20","author":"Cui","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.metabol.2019.03.003_bb0170","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00125-013-2926-9","article-title":"Thiazolidinediones partially reverse the metabolic disturbances observed in Bscl2\/seipin-deficient mice","volume":"56","author":"Prieur","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2019.03.003_bb0175","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1128\/MCB.06465-11","article-title":"Berardinelli-seip congenital lipodystrophy 2\/seipin is a cell-autonomous regulator of lipolysis essential for adipocyte differentiation","volume":"32","author":"Chen","year":"2012","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.metabol.2019.03.003_bb0180","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1096\/fj.10-173716","article-title":"Role for PPARgamma in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts","volume":"25","author":"Moran-Salvador","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2019.03.003_bb0185","doi-asserted-by":"crossref","first-page":"34268","DOI":"10.1074\/jbc.M300043200","article-title":"Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass","volume":"278","author":"Gavrilova","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2019.03.003_bb0190","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.1128\/MCB.23.20.7222-7229.2003","article-title":"Targeted elimination of peroxisome proliferator-activated receptor gamma in beta cells leads to abnormalities in islet mass without compromising glucose homeostasis","volume":"23","author":"Rosen","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.metabol.2019.03.003_bb0195","doi-asserted-by":"crossref","first-page":"25440","DOI":"10.1074\/jbc.M113.486852","article-title":"Peroxisome proliferator-activated receptor gamma (PPARgamma) and its target genes are downstream effectors of FoxO1 protein in islet beta-cells: mechanism of beta-cell compensation and failure","volume":"288","author":"Gupta","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2019.03.003_bb0200","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1152\/physrev.1997.77.3.731","article-title":"Cellular energy utilization and molecular origin of standard metabolic rate in mammals","volume":"77","author":"Rolfe","year":"1997","journal-title":"Physiol Rev"},{"key":"10.1016\/j.metabol.2019.03.003_bb0205","doi-asserted-by":"crossref","first-page":"17453","DOI":"10.18632\/oncotarget.15294","article-title":"The effects of graded levels of calorie restriction: VIII. Impact of short term calorie and protein restriction on basal metabolic rate in the C57BL\/6 mouse","volume":"8","author":"Mitchell","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.metabol.2019.03.003_bb0210","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.metabol.2006.10.012","article-title":"Short-term energy restriction reduces resting energy expenditure in patients with HIV lipodystrophy and hypermetabolism","volume":"56","author":"Kosmiski","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2019.03.003_bb0215","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2337\/diabetes.49.5.677","article-title":"Fuel selection in human skeletal muscle in insulin resistance: a reexamination","volume":"49","author":"Kelley","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2019.03.003_bb0220","doi-asserted-by":"crossref","first-page":"E1009","DOI":"10.1152\/ajpendo.90558.2008","article-title":"Metabolic flexibility and insulin resistance","volume":"295","author":"Galgani","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2019.03.003_bb0225","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00592-010-0245-x","article-title":"Metabolic inflexibility is a common feature of impaired fasting glycaemia and impaired glucose tolerance","volume":"48","author":"Faerch","year":"2011","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.metabol.2019.03.003_bb0230","doi-asserted-by":"crossref","first-page":"14623","DOI":"10.1073\/pnas.96.25.14623","article-title":"Torpor in mice is induced by both leptin-dependent and -independent mechanisms","volume":"96","author":"Gavrilova","year":"1999","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049519300514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049519300514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:18:54Z","timestamp":1758428334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049519300514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":46,"alternative-id":["S0026049519300514"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2019.03.003","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic PPAR\u03b3 deletion in mice provokes lipoatrophy, organomegaly, severe type 2 diabetes and metabolic inflexibility","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2019.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}